Barbituric Acid Market Size, Share, Growth, and Global Industry Analysis by Type (Pharmaceutical Grade Barbituric, Industrial Grade Barbituric Acid), By Application (VB2, Barbiturate, Dye Industries and Others), Regional Outlook, and Forecast From 2026 To 2035

Last Updated: 12 March 2026
SKU ID: 27854157

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

BARBITURIC ACID MARKET OVERVIEW

The global barbituric acid market stood at USD 0.02 Billion in 2026 and maintaining a strong growth trajectory to reach USD 0.03 Billion by 2035 with a CAGR of 4.6% from 2026 to 2035.

I need the full data tables, segment breakdown, and competitive landscape for detailed regional analysis and revenue estimates.

Download Free Sample

Barbituric Acid is an organic compound based on a pyrimidine heterocyclic skeleton. It also goes by the name of malonylurea. Barbituric acid is an odorless powder soluble in water. It is the parent compound of barbiturate dugs. Nonetheless, barbituric acid itself is not pharmacologically active. The properties of its derivatives vary depending on the side-groups attached to it. This enables barbituric acid to be used for multiple purposes.

Barbituric acid has the potential to be developed into several drugs. The medical value of these drugs not realized until late. Barbituric acid has been proved useful as a sleeping pill. Essentially it proved effective in putting dogs to sleep. They were used in therapy of veterans who were diagnosed with Post Traumatic Stress Disorder [PTSD]. It saw a surge in usage by defense officials who used it as a ‘truth serum’ to obtain information.

KEY FINDINGS

  • Market Size and Growth: The global Barbituric Acid Market size stood at USD 0.02 Billion in 2026 growing further to USD 0.03 Billion by 2035 at an estimated CAGR of 4.6% from 2026 to 2035.
  • Key Market Driver: Pharmaceutical applications account for 41% consumption, barbiturate demand growth 13%, neurological drug prescriptions increase 11%, and process optimization improves yields by 8–10%.
  • Major Market Restraint: Regulatory restrictions reduce barbiturate utilization by 18%, alternative sedatives adoption increases 25%, compliance costs rise 15%, and production constraints affect 12% of manufacturers.
  • Emerging Trends: Sustainable synthesis adoption reaches 56%, eco-friendly manufacturing investment rises 19%, waste reduction technologies improve efficiency by 15%, and advanced high-purity production exceeds 99.6%.
  • Regional Leadership: Asia-Pacific leads with 37.4% share, China contributes 57% regional production, India accounts for 21% output, and global production concentration approaches 95%.
  • Competitive Landscape: Top producers control 85% market share, China dominates 95% global production, pharmaceutical manufacturing facilities exceed 70 units, and strategic R&D investment growth reaches 22%.
  • Market Segmentation: Pharmaceutical Grade Barbituric Acid segment holds 61.3% share, high-purity grade accounts 68.64% demand, pharmaceutical intermediates represent 59.52% application, and purity levels reach 95–99%.
  • Recent Development: Patent filings increase 12 innovations, eco-friendly technology investment grows 19%, manufacturing efficiency improves 15%, and pharmaceutical demand expansion reaches 13%.

COVID-19 Impact:

Utility of Product as a Covid Vaccine Increased Market Share

The COVID-19 pandemic has been unprecedented and staggering, with barbituric acid market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The rise in CAGR is attributable to the barbituric acid market growth and demand returning to pre-pandemic levels once the pandemic is over.

The effects of the COVID-19 pandemic are already being felt on a global level, the global barbituric acid market was significantly influenced. The outbreak of COVID-19 had a negative impact on several markets. Various countries went into lockdown. With sudden pandemic, all kinds of businesses observed disruptions. The pandemic had a significant impact on the barbituric acid market.

There was a rapid surge in the requirement for barbituric acid. According to an article on NRC Research Press, an experiment was conducted to develop compounds to fight 2 enzymes of SARS-CoV 2. The methodology developed; generated a barbituric acid based on sulfonamides. These sulfonamides were docked with unliganded active site of SARS-CoV 2 enzymes. The concluded that ligand efficiency values against the target enzymes and DNA-lyase inhibition results of the new compounds were promising.

This led to the increased usage of barbituric acid in making of the vaccine for the novel corona virus. Furthermore, the global barbituric acid market growth saw a surge considering its usage as anesthesia. As the lockdown was imposed, the confinement of the civilization and their inability to undertake day-to-day activities caused a increased number of patients diagnosed with insomnia. An article on healthline stated that 75% of adults aged 65 and older were diagnosed with insomnia. Hence there was a increased usage of barbituric acid as a sleeping drug to help the patients fall asleep.

LATEST TRENDS

Latest Derivatives to Boost Market Share

The global barbituric acid market growth is expected to see a surge in usage considering recent developments in its derivatives. ScienceDirect published a journal on new barbituric acids which experimented with the ligand efficiency of various derivatives. The derivatives were named 4 and 5 and synthesized with a green and efficient protocol. The results indicated that compounds 4 and 5 possess a significant effect as reactive oxygen scavenger in comparison to standard drugs. They had better drug character likeness candidate rather than compounds.

A research paper published on PubMed Central regarding barbituric acids stated that its derivatives have ability to fight against hepatocellular carcinoma. The experiment investigated the anti-tumor effects of barbituric acid on the HCC cells. The results which were confirmed by a micro-analysis showed that BA-5 treatment influenced cancer cells motility and growth-related pathways. To conclude, barbituric acid is a new candidate for HCC and sorafenib-resistant HCC therapy.

  • According to the International Narcotics Control Board (INCB), global phenobarbital manufacture increased from 385 tons in 2015 to 416 tons in 2016, representing an approximate 8% increase in one year, indicating rising demand for barbituric acid-based pharmaceutical intermediates.
  • According to the European Union Drugs Agency, more than 2,500 barbiturate derivatives have been synthesized, but only about 50 compounds are used medically, meaning around 2% of developed derivatives reach medical use, demonstrating large research activity but limited clinical adoption.
Global-Barbituric-Acid-Market-Share,-By-Type,-2035

ask for customizationDownload Free Sample to learn more about this report

BARBITURIC ACID MARKET SEGMENTATION

By Type

Based on type, the market is bifurcated as follows: Pharmaceutical Grade Barbituric Acid, Industrial Grade Barbituric Acid. The pharmaceuticals grade accounted for the largest market share.

  • Pharmaceutical Grade Barbituric Acid: Pharmaceutical grade barbituric acid is manufactured with extremely high purity under strict quality regulations suitable for medical and pharmaceutical applications. It is primarily used as an intermediate in producing barbiturate drugs and other specialized pharmaceutical compounds.
  • Industrial Grade Barbituric Acid: Industrial grade barbituric acid is produced for broader chemical manufacturing where slightly lower purity levels are acceptable. It is widely utilized in the production of dyes, pigments, corrosion inhibitors, and other industrial chemical formulations.

By Application

Based on application, the market is segmented as follows: VB2, Barbiturate, Dye Intermediates and others.

  • VB2 (Vitamin B2 / Riboflavin): Vitamin B2, also known as riboflavin, is an essential nutrient that plays a key role in energy production and metabolic processes in the body. It is widely produced for use in pharmaceutical supplements, fortified foods, and animal feed.
  • Barbiturate: Barbiturates are chemical compounds derived from barbituric acid that act as depressants on the central nervous system. They have been used in medicine as sedatives, anesthetics, and anticonvulsants, though their use is now limited due to safety concerns.
  • Dye Intermediates: Dye intermediates are chemical substances used as raw materials in the production of dyes and pigments. They are essential in manufacturing a wide variety of colors used in textiles, plastics, inks, and other industrial products.
  • Others: The “others” category includes various specialty chemicals and compounds produced for specific industrial or research applications. These products support diverse sectors such as pharmaceuticals, agriculture, and chemical manufacturing.

DRIVING FACTORS

Increased Geriatric Population to Propel Growth

The global barbituric acid market growth is expected to rise considering the increase in the geriatric population. There is increasing rate of insomnia leading to an increasing demand for sleeping medication. This is expected to drive the barbituric acid market. An article on healthline stated that 75% of adults aged 65 and older were diagnosed with insomnia . World Ageing Report of 2019 states that Japan has the world’s fastest ageing population. The report concludes that the population above the age of 65 in Japan was 35.524 million in 2019 this comprises about 28% of the population. It is projected to reach 37.278 million by 2030 comprising about 30.9% of the population. As the number of geriatric populations increases in the coming years, the growth of barbituric acid market size will expand in the forthcoming years.

  • According to the International Narcotics Control Board, phenobarbital accounted for 447 tons out of 543 tons of total barbiturate production in 2007, representing approximately 78% of total global barbiturate output, significantly driving demand for barbituric acid intermediates.
  • According to INCB manufacturing statistics, China accounts for around 49% of global barbiturate production while India contributes about 24%, meaning over 70% of global supply originates from these two countries.

Increased Cancer Patients to Increase the Use of Barbituric Acid

The global barbituric acid market growth is anticipated to spike owing to the increase in the number of aged people across the globe. Research published on PubMed Central had experimented barbituric acid against hepatocellular carcinoma cells. The results declared barbituric acid as a new candidate for HCC therapy. With the increasing number of old aged people, there will be a rise in several types of cancers as elderly individuals are more vulnerable. There has also been a drastic rise in the number of cancer patients. The International Agency for Research on Cancer [IRAC] updated the Globocon data of 2020 with an estimated 19.3 million cancer cases. Therefore, the rising stress of cancer cases would boost the growth of the global barbituric acid markets.

RESTRAINING FACTORS

Addictive Nature Forms a Habit of Danger

There are several factors that could affect the global barbituric acid market growth. Patients may develop a tolerance and habit for the barbiturates. They pose a danger as a drug as it is widely used by suicides. It also presents the problem of automatism which might cause the patient to overdose on the drug. Barbiturates and alcohol are eliminated by the same system of enzymes in the liver. If one were to consume both are a once, it might lead to liver failure or death.

  • According to the United Nations Convention on Psychotropic Substances, 12 barbiturate compounds are under international control schedules. These controlled substances represent a significant portion of clinically used barbiturates, limiting broader pharmaceutical production.
  • According to the International Narcotics Control Board, global phenobarbital consumption decreased from 218 tons in 2015 to 172 tons in 2016, representing an approximate 21% decline in one year, which can reduce upstream demand for barbituric acid.
  • ask for customizationDownload Free Sample to learn more about this report

  •  

BARBITURIC ACID MARKET REGIONAL INSIGHTS

North America Leads Market Share Owing to Increasing Geriatric Population

North America holds the largest part of the global barbituric acid market share. This is due to increasing geriatric old age population and the rising number of HCC cancer patients. The increase in the number of old aged people is a direct contributing factor to a requirement of sleep medication. Insomnia is  growing issue among people aged 60 plus. As shared by SleepFoundation, almost 30% of the adults live with insomnia.

Asia Pacific holds the second-largest part of the global barbituric acid market share. This is due to increasing geriatric old age population. The increase in the number of old aged people is a direct contributing factor to a requirement of insomnia. These factors combined with the rise in the use of barbituric acid in the region contribute to the dominance of this region.

KEY INDUSTRY PLAYERS

Market Players to Boost Market Growth

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

  • Zhengzhou Lifeng Chemical (China): China accounts for approximately 49% of global barbiturate manufacturing, making the country the dominant production hub. Companies such as Zhengzhou Lifeng Chemical operate within this ecosystem supplying intermediates including barbituric acid.
  • Hebei Chengxin (China): China and India together contribute over 70% of global barbiturate production capacity, providing a strong supply chain base for barbituric acid manufacturing where companies like Hebei Chengxin participate in pharmaceutical intermediate production.

List Of Top Barbituric Acid Companies

  • Zhengzhou Lifeng Chemical [China]
  • Hebei Chengxin [China]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.

Barbituric Acid Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 0.02 Billion in 2026

Market Size Value By

US$ 0.03 Billion by 2035

Growth Rate

CAGR of 4.6% from 2026 to 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Types

  • Pharmaceutical Grade Barbituric Acid
  • Industrial Grade Barbituric Acid

By Application

  • VB2
  • Barbiturate
  • Dye Intermediates
  • Others

FAQs

Stay Ahead of Your Rivals Get instant access to complete data, competitive insights, and decade-long market forecasts. Download FREE Sample